

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | complement activation, alternative pathway (GO:0006957) | 8.36383658 |
| 2 | blood coagulation, intrinsic pathway (GO:0007597) | 7.68201278 |
| 3 | phosphate ion transmembrane transport (GO:0035435) | 7.51384210 |
| 4 | left/right axis specification (GO:0070986) | 7.27624147 |
| 5 | regulation of bile acid biosynthetic process (GO:0070857) | 6.99785439 |
| 6 | regulation of protein activation cascade (GO:2000257) | 6.92170170 |
| 7 | regulation of complement activation (GO:0030449) | 6.83523117 |
| 8 | embryonic retina morphogenesis in camera-type eye (GO:0060059) | 6.76364860 |
| 9 | phosphate ion transport (GO:0006817) | 6.46537819 |
| 10 | negative regulation of sterol transport (GO:0032372) | 6.36652367 |
| 11 | negative regulation of cholesterol transport (GO:0032375) | 6.36652367 |
| 12 | regulation of cholesterol esterification (GO:0010872) | 6.18356440 |
| 13 | low-density lipoprotein particle remodeling (GO:0034374) | 5.94926708 |
| 14 | high-density lipoprotein particle remodeling (GO:0034375) | 5.90537144 |
| 15 | regulation of fibrinolysis (GO:0051917) | 5.77354259 |
| 16 | arginine catabolic process (GO:0006527) | 5.77221195 |
| 17 | phospholipid efflux (GO:0033700) | 5.68918024 |
| 18 | imidazole-containing compound metabolic process (GO:0052803) | 5.66335084 |
| 19 | fibrinolysis (GO:0042730) | 5.64012121 |
| 20 | phospholipid homeostasis (GO:0055091) | 5.59717977 |
| 21 | reverse cholesterol transport (GO:0043691) | 5.57773029 |
| 22 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.52835879 |
| 23 | hepatocyte differentiation (GO:0070365) | 5.43180516 |
| 24 | urea metabolic process (GO:0019627) | 5.41968168 |
| 25 | drug catabolic process (GO:0042737) | 5.36421528 |
| 26 | regulation of sarcomere organization (GO:0060297) | 5.21224176 |
| 27 | positive regulation of cell cycle checkpoint (GO:1901978) | 5.10596516 |
| 28 | response to vitamin A (GO:0033189) | 5.06776153 |
| 29 | urea cycle (GO:0000050) | 5.04487422 |
| 30 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.97314048 |
| 31 | protein carboxylation (GO:0018214) | 4.97314048 |
| 32 | nitrogen cycle metabolic process (GO:0071941) | 4.90412629 |
| 33 | omega-hydroxylase P450 pathway (GO:0097267) | 4.88362816 |
| 34 | plasma lipoprotein particle remodeling (GO:0034369) | 4.81312959 |
| 35 | protein-lipid complex remodeling (GO:0034368) | 4.81312959 |
| 36 | macromolecular complex remodeling (GO:0034367) | 4.81312959 |
| 37 | negative regulation of fibrinolysis (GO:0051918) | 4.80057474 |
| 38 | cholesterol efflux (GO:0033344) | 4.79293842 |
| 39 | oxidative demethylation (GO:0070989) | 4.77127175 |
| 40 | response to methylmercury (GO:0051597) | 4.68895949 |
| 41 | plasma lipoprotein particle assembly (GO:0034377) | 4.60125520 |
| 42 | protein activation cascade (GO:0072376) | 4.53195073 |
| 43 | cerebellar granule cell differentiation (GO:0021707) | 4.48838807 |
| 44 | plasma lipoprotein particle clearance (GO:0034381) | 4.29769616 |
| 45 | bile acid biosynthetic process (GO:0006699) | 4.28207504 |
| 46 | venous blood vessel morphogenesis (GO:0048845) | 4.25020864 |
| 47 | negative regulation of hemostasis (GO:1900047) | 4.17166184 |
| 48 | negative regulation of blood coagulation (GO:0030195) | 4.17166184 |
| 49 | alkaloid metabolic process (GO:0009820) | 4.02988368 |
| 50 | regulation of lipoprotein metabolic process (GO:0050746) | 3.95216650 |
| 51 | regulation of humoral immune response (GO:0002920) | 3.94778751 |
| 52 | protein-lipid complex assembly (GO:0065005) | 3.94430301 |
| 53 | lymphangiogenesis (GO:0001946) | 3.93884220 |
| 54 | negative regulation of norepinephrine secretion (GO:0010700) | 3.91955586 |
| 55 | cellular glucuronidation (GO:0052695) | 3.89469422 |
| 56 | pyrimidine nucleobase catabolic process (GO:0006208) | 3.88937021 |
| 57 | bile acid metabolic process (GO:0008206) | 3.86021640 |
| 58 | negative regulation of coagulation (GO:0050819) | 3.85284091 |
| 59 | alpha-linolenic acid metabolic process (GO:0036109) | 3.82081459 |
| 60 | epoxygenase P450 pathway (GO:0019373) | 3.80932973 |
| 61 | bile acid and bile salt transport (GO:0015721) | 3.78745355 |
| 62 | negative regulation of protein activation cascade (GO:2000258) | 3.77421306 |
| 63 | arginine metabolic process (GO:0006525) | 3.71182493 |
| 64 | nucleobase catabolic process (GO:0046113) | 3.69637469 |
| 65 | negative regulation of wound healing (GO:0061045) | 3.68748753 |
| 66 | complement activation (GO:0006956) | 3.65913357 |
| 67 | plasma lipoprotein particle organization (GO:0071827) | 3.62358757 |
| 68 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.54898621 |
| 69 | glucuronate metabolic process (GO:0019585) | 3.54561419 |
| 70 | uronic acid metabolic process (GO:0006063) | 3.54561419 |
| 71 | negative regulation of complement activation (GO:0045916) | 3.53493225 |
| 72 | positive regulation of renal sodium excretion (GO:0035815) | 3.52891388 |
| 73 | glyoxylate metabolic process (GO:0046487) | 3.45562914 |
| 74 | mRNA modification (GO:0016556) | 3.44011663 |
| 75 | negative regulation of lipid transport (GO:0032369) | 3.39711507 |
| 76 | negative regulation of lipase activity (GO:0060192) | 3.35231619 |
| 77 | exogenous drug catabolic process (GO:0042738) | 3.34353414 |
| 78 | diacylglycerol metabolic process (GO:0046339) | 3.33296826 |
| 79 | protein-lipid complex subunit organization (GO:0071825) | 3.32450260 |
| 80 | drug metabolic process (GO:0017144) | 3.31782270 |
| 81 | N-acetylneuraminate metabolic process (GO:0006054) | 3.30383308 |
| 82 | regulation of sterol transport (GO:0032371) | 3.28756333 |
| 83 | regulation of cholesterol transport (GO:0032374) | 3.28756333 |
| 84 | response to pheromone (GO:0019236) | 3.27905373 |
| 85 | response to manganese ion (GO:0010042) | 3.27784610 |
| 86 | regulation of apoptotic cell clearance (GO:2000425) | 3.26214594 |
| 87 | glycine metabolic process (GO:0006544) | 3.23359353 |
| 88 | neuronal stem cell maintenance (GO:0097150) | 3.21874265 |
| 89 | response to vitamin E (GO:0033197) | 3.19103922 |
| 90 | amino-acid betaine transport (GO:0015838) | 3.18194938 |
| 91 | carnitine transport (GO:0015879) | 3.18194938 |
| 92 | positive regulation of glycolytic process (GO:0045821) | 3.16502961 |
| 93 | regulation of response to tumor cell (GO:0002834) | 3.11098101 |
| 94 | positive regulation of response to tumor cell (GO:0002836) | 3.11098101 |
| 95 | positive regulation of immune response to tumor cell (GO:0002839) | 3.11098101 |
| 96 | regulation of immune response to tumor cell (GO:0002837) | 3.11098101 |
| 97 | serine family amino acid metabolic process (GO:0009069) | 3.10820475 |
| 98 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 3.06158818 |
| 99 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.06062463 |
| 100 | heme transport (GO:0015886) | 3.06056100 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 3.82210204 |
| 2 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.78781262 |
| 3 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.17145801 |
| 4 | TAF15_26573619_Chip-Seq_HEK293_Human | 3.10712246 |
| 5 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.08404852 |
| 6 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 2.97220048 |
| 7 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.96811655 |
| 8 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 2.75606023 |
| 9 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 2.57929963 |
| 10 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 2.47940203 |
| 11 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.47743515 |
| 12 | GATA1_22025678_ChIP-Seq_K562_Human | 2.40021076 |
| 13 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 2.35580488 |
| 14 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.31088611 |
| 15 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 2.20444629 |
| 16 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.16237936 |
| 17 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 2.07096833 |
| 18 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.07033217 |
| 19 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.92105844 |
| 20 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.88659121 |
| 21 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.87829112 |
| 22 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.84846279 |
| 23 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.84094787 |
| 24 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.83836787 |
| 25 | CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 1.78252936 |
| 26 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 1.78111336 |
| 27 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.77766789 |
| 28 | HNFA_21074721_ChIP-Seq_CACO-2_Human | 1.76867676 |
| 29 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.76406915 |
| 30 | GATA6_21074721_ChIP-Seq_CACO-2_Human | 1.75007072 |
| 31 | * NFYA_21822215_ChIP-Seq_K562_Human | 1.74443373 |
| 32 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.73584035 |
| 33 | PHF8_20622853_ChIP-Seq_HELA_Human | 1.73312998 |
| 34 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 1.72170435 |
| 35 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.71563166 |
| 36 | CBX2_22325352_ChIP-Seq_293T-Rex_Human | 1.70815114 |
| 37 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.69766231 |
| 38 | ETV1_20927104_ChIP-Seq_GIST48_Human | 1.69272807 |
| 39 | RBPJ_21746931_ChIP-Seq_IB4_Human | 1.66589915 |
| 40 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.66169542 |
| 41 | P300_18555785_Chip-Seq_ESCs_Mouse | 1.65206440 |
| 42 | KLF4_18555785_Chip-Seq_ESCs_Mouse | 1.64943705 |
| 43 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 1.64097564 |
| 44 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 1.64086870 |
| 45 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 1.62270451 |
| 46 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.60300008 |
| 47 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.60091435 |
| 48 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 1.59827533 |
| 49 | * PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.58596879 |
| 50 | CTCF_18555785_Chip-Seq_ESCs_Mouse | 1.57043605 |
| 51 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.55828659 |
| 52 | * NFYB_21822215_ChIP-Seq_K562_Human | 1.55533485 |
| 53 | ZFX_18555785_Chip-Seq_ESCs_Mouse | 1.53914731 |
| 54 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.53512778 |
| 55 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.53171380 |
| 56 | PU1_27457419_Chip-Seq_LIVER_Mouse | 1.52758977 |
| 57 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 1.52263517 |
| 58 | ESRRB_18555785_Chip-Seq_ESCs_Mouse | 1.50751052 |
| 59 | * TBL1_22424771_ChIP-Seq_293T_Human | 1.49317090 |
| 60 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.48637299 |
| 61 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.46390267 |
| 62 | TP53_16413492_ChIP-PET_HCT116_Human | 1.46230931 |
| 63 | PCGF4_22325352_ChIP-Seq_293T-Rex_Human | 1.44061350 |
| 64 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.40629996 |
| 65 | VDR_22108803_ChIP-Seq_LS180_Human | 1.38351284 |
| 66 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.37010730 |
| 67 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.36159315 |
| 68 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.32746838 |
| 69 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.30876948 |
| 70 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.30702448 |
| 71 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.28326709 |
| 72 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.27942441 |
| 73 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.25851587 |
| 74 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.25149371 |
| 75 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.22718115 |
| 76 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.22647586 |
| 77 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.22647586 |
| 78 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.22208911 |
| 79 | * BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.21218660 |
| 80 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.20033536 |
| 81 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.17225766 |
| 82 | TCF4_23295773_ChIP-Seq_U87_Human | 1.16592817 |
| 83 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.15888067 |
| 84 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.13481503 |
| 85 | STAT3_23295773_ChIP-Seq_U87_Human | 1.12150326 |
| 86 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.10799574 |
| 87 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.09616244 |
| 88 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.09106676 |
| 89 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.08476891 |
| 90 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.08298578 |
| 91 | * UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.07127712 |
| 92 | * ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.04504130 |
| 93 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.03502958 |
| 94 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.01229614 |
| 95 | * P300_19829295_ChIP-Seq_ESCs_Human | 1.00841381 |
| 96 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.96627825 |
| 97 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.95445559 |
| 98 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 0.93216031 |
| 99 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.90789223 |
| 100 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 0.90677249 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002138_abnormal_hepatobiliary_system | 9.61284678 |
| 2 | MP0003195_calcinosis | 6.99143564 |
| 3 | MP0002139_abnormal_hepatobiliary_system | 5.03915592 |
| 4 | MP0010368_abnormal_lymphatic_system | 4.84370998 |
| 5 | MP0005085_abnormal_gallbladder_physiolo | 4.62089884 |
| 6 | MP0000569_abnormal_digit_pigmentation | 3.76758843 |
| 7 | MP0005365_abnormal_bile_salt | 3.47922043 |
| 8 | MP0003252_abnormal_bile_duct | 3.41931598 |
| 9 | MP0010329_abnormal_lipoprotein_level | 2.87591444 |
| 10 | MP0002876_abnormal_thyroid_physiology | 2.49518598 |
| 11 | MP0001666_abnormal_nutrient_absorption | 2.22286296 |
| 12 | MP0005645_abnormal_hypothalamus_physiol | 2.19912699 |
| 13 | MP0001661_extended_life_span | 2.13804400 |
| 14 | MP0003868_abnormal_feces_composition | 2.06833972 |
| 15 | MP0003880_abnormal_central_pattern | 1.68684303 |
| 16 | MP0000604_amyloidosis | 1.68074545 |
| 17 | MP0001879_abnormal_lymphatic_vessel | 1.65084418 |
| 18 | MP0008057_abnormal_DNA_replication | 1.63990416 |
| 19 | MP0004742_abnormal_vestibular_system | 1.56921464 |
| 20 | MP0002118_abnormal_lipid_homeostasis | 1.49998223 |
| 21 | MP0006276_abnormal_autonomic_nervous | 1.46526151 |
| 22 | MP0005464_abnormal_platelet_physiology | 1.44128065 |
| 23 | MP0005332_abnormal_amino_acid | 1.41582754 |
| 24 | MP0002928_abnormal_bile_duct | 1.34185109 |
| 25 | MP0003879_abnormal_hair_cell | 1.31803414 |
| 26 | MP0003690_abnormal_glial_cell | 1.28001612 |
| 27 | MP0005187_abnormal_penis_morphology | 1.26434720 |
| 28 | MP0005379_endocrine/exocrine_gland_phen | 1.20848543 |
| 29 | MP0005451_abnormal_body_composition | 1.17859850 |
| 30 | MP0005164_abnormal_response_to | 1.17223999 |
| 31 | MP0003943_abnormal_hepatobiliary_system | 1.17041211 |
| 32 | MP0005408_hypopigmentation | 1.16878825 |
| 33 | MP0002254_reproductive_system_inflammat | 1.12431558 |
| 34 | MP0004883_abnormal_blood_vessel | 1.11933866 |
| 35 | MP0000609_abnormal_liver_physiology | 1.10367780 |
| 36 | MP0005360_urolithiasis | 1.09329024 |
| 37 | MP0003122_maternal_imprinting | 1.08877075 |
| 38 | MP0001486_abnormal_startle_reflex | 1.08687087 |
| 39 | MP0005220_abnormal_exocrine_pancreas | 1.07734014 |
| 40 | MP0000383_abnormal_hair_follicle | 1.05932294 |
| 41 | MP0000003_abnormal_adipose_tissue | 1.03514750 |
| 42 | MP0003890_abnormal_embryonic-extraembry | 1.02378256 |
| 43 | MP0009115_abnormal_fat_cell | 0.99999394 |
| 44 | MP0003632_abnormal_nervous_system | 0.98415212 |
| 45 | MP0001764_abnormal_homeostasis | 0.96473243 |
| 46 | MP0005646_abnormal_pituitary_gland | 0.94357199 |
| 47 | MP0002078_abnormal_glucose_homeostasis | 0.93971483 |
| 48 | MP0005386_behavior/neurological_phenoty | 0.92522704 |
| 49 | MP0004924_abnormal_behavior | 0.92522704 |
| 50 | MP0003638_abnormal_response/metabolism_ | 0.89149368 |
| 51 | MP0004019_abnormal_vitamin_homeostasis | 0.86184674 |
| 52 | MP0004130_abnormal_muscle_cell | 0.85601784 |
| 53 | MP0002168_other_aberrant_phenotype | 0.85327263 |
| 54 | MP0005376_homeostasis/metabolism_phenot | 0.84580278 |
| 55 | MP0003953_abnormal_hormone_level | 0.80871561 |
| 56 | MP0003959_abnormal_lean_body | 0.80017588 |
| 57 | MP0003011_delayed_dark_adaptation | 0.79642794 |
| 58 | MP0001915_intracranial_hemorrhage | 0.79534378 |
| 59 | MP0000598_abnormal_liver_morphology | 0.77932579 |
| 60 | MP0004272_abnormal_basement_membrane | 0.77186484 |
| 61 | MP0009642_abnormal_blood_homeostasis | 0.76288615 |
| 62 | MP0001944_abnormal_pancreas_morphology | 0.74430464 |
| 63 | MP0001501_abnormal_sleep_pattern | 0.74355994 |
| 64 | MP0003950_abnormal_plasma_membrane | 0.73751844 |
| 65 | MP0005319_abnormal_enzyme/_coenzyme | 0.68897742 |
| 66 | MP0002098_abnormal_vibrissa_morphology | 0.67811798 |
| 67 | MP0005334_abnormal_fat_pad | 0.67717973 |
| 68 | MP0003646_muscle_fatigue | 0.66981685 |
| 69 | MP0003878_abnormal_ear_physiology | 0.66331162 |
| 70 | MP0005377_hearing/vestibular/ear_phenot | 0.66331162 |
| 71 | MP0008469_abnormal_protein_level | 0.65038082 |
| 72 | MP0001346_abnormal_lacrimal_gland | 0.63365677 |
| 73 | MP0005395_other_phenotype | 0.63091132 |
| 74 | MP0005535_abnormal_body_temperature | 0.62879692 |
| 75 | MP0003631_nervous_system_phenotype | 0.61768105 |
| 76 | MP0002971_abnormal_brown_adipose | 0.60998735 |
| 77 | MP0005647_abnormal_sex_gland | 0.60519254 |
| 78 | MP0003633_abnormal_nervous_system | 0.59483690 |
| 79 | MP0005551_abnormal_eye_electrophysiolog | 0.59335048 |
| 80 | MP0005636_abnormal_mineral_homeostasis | 0.59125587 |
| 81 | MP0008875_abnormal_xenobiotic_pharmacok | 0.58511506 |
| 82 | MP0005076_abnormal_cell_differentiation | 0.58324652 |
| 83 | MP0004147_increased_porphyrin_level | 0.56489993 |
| 84 | MP0000647_abnormal_sebaceous_gland | 0.55217985 |
| 85 | MP0005375_adipose_tissue_phenotype | 0.54493185 |
| 86 | MP0005670_abnormal_white_adipose | 0.54190470 |
| 87 | MP0003123_paternal_imprinting | 0.54056603 |
| 88 | MP0000920_abnormal_myelination | 0.53439890 |
| 89 | MP0005083_abnormal_biliary_tract | 0.53231039 |
| 90 | MP0008004_abnormal_stomach_pH | 0.51887255 |
| 91 | MP0002229_neurodegeneration | 0.51213920 |
| 92 | MP0008770_decreased_survivor_rate | 0.51083319 |
| 93 | MP0002909_abnormal_adrenal_gland | 0.50370835 |
| 94 | MP0000249_abnormal_blood_vessel | 0.49838826 |
| 95 | MP0002733_abnormal_thermal_nociception | 0.47278767 |
| 96 | MP0005084_abnormal_gallbladder_morpholo | 0.46630836 |
| 97 | MP0002067_abnormal_sensory_capabilities | 0.46460293 |
| 98 | MP0001324_abnormal_eye_pigmentation | 0.45677321 |
| 99 | MP0005389_reproductive_system_phenotype | 0.44864890 |
| 100 | MP0001919_abnormal_reproductive_system | 0.44372452 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Prolonged partial thromboplastin time (HP:0003645) | 9.79397786 |
| 2 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 9.45880304 |
| 3 | Osteomalacia (HP:0002749) | 8.06872633 |
| 4 | Complement deficiency (HP:0004431) | 7.08068840 |
| 5 | Abnormality of pyrimidine metabolism (HP:0004353) | 6.03947477 |
| 6 | Generalized aminoaciduria (HP:0002909) | 5.83586914 |
| 7 | Glomerulonephritis (HP:0000099) | 5.60396309 |
| 8 | Abnormality of complement system (HP:0005339) | 5.19325547 |
| 9 | Abnormality of the common coagulation pathway (HP:0010990) | 4.72767123 |
| 10 | Joint hemorrhage (HP:0005261) | 4.68219924 |
| 11 | Intrahepatic cholestasis (HP:0001406) | 4.52323138 |
| 12 | Menorrhagia (HP:0000132) | 4.24041677 |
| 13 | Fat malabsorption (HP:0002630) | 4.22815743 |
| 14 | Rickets (HP:0002748) | 3.95473557 |
| 15 | Steatorrhea (HP:0002570) | 3.84709969 |
| 16 | Abnormality of nucleobase metabolism (HP:0010932) | 3.80520157 |
| 17 | Scanning speech (HP:0002168) | 3.77650724 |
| 18 | Hyperphosphaturia (HP:0003109) | 3.56675254 |
| 19 | Arthropathy (HP:0003040) | 3.53532096 |
| 20 | Abnormality of vitamin metabolism (HP:0100508) | 3.43302623 |
| 21 | Conjugated hyperbilirubinemia (HP:0002908) | 3.37929343 |
| 22 | Acanthocytosis (HP:0001927) | 3.33911535 |
| 23 | Hypobetalipoproteinemia (HP:0003563) | 3.32906318 |
| 24 | Wrist flexion contracture (HP:0001239) | 3.29448547 |
| 25 | Hypophosphatemic rickets (HP:0004912) | 3.16733458 |
| 26 | Peritonitis (HP:0002586) | 3.10856460 |
| 27 | Systemic lupus erythematosus (HP:0002725) | 3.06939264 |
| 28 | Nephritis (HP:0000123) | 3.05810774 |
| 29 | Xanthomatosis (HP:0000991) | 3.00004906 |
| 30 | Decreased subcutaneous fat (HP:0001002) | 2.97454823 |
| 31 | Abnormal urine phosphate concentration (HP:0012599) | 2.95963253 |
| 32 | Sensorimotor neuropathy (HP:0007141) | 2.94502385 |
| 33 | Vascular calcification (HP:0004934) | 2.92159744 |
| 34 | Papillary thyroid carcinoma (HP:0002895) | 2.90298477 |
| 35 | Abnormality of the intrinsic pathway (HP:0010989) | 2.88101141 |
| 36 | Abnormality of purine metabolism (HP:0004352) | 2.78115969 |
| 37 | Hypercholesterolemia (HP:0003124) | 2.72195724 |
| 38 | Hypophosphatemia (HP:0002148) | 2.63482103 |
| 39 | Glycosuria (HP:0003076) | 2.61151532 |
| 40 | Abnormality of urine glucose concentration (HP:0011016) | 2.61151532 |
| 41 | Cardiovascular calcification (HP:0011915) | 2.53391043 |
| 42 | Bile duct proliferation (HP:0001408) | 2.48171024 |
| 43 | Abnormal biliary tract physiology (HP:0012439) | 2.48171024 |
| 44 | Gonadotropin excess (HP:0000837) | 2.46961781 |
| 45 | Toxemia of pregnancy (HP:0100603) | 2.39678144 |
| 46 | Gastrointestinal infarctions (HP:0005244) | 2.37417201 |
| 47 | Macroorchidism (HP:0000053) | 2.33903286 |
| 48 | Cholecystitis (HP:0001082) | 2.32623515 |
| 49 | Abnormal gallbladder physiology (HP:0012438) | 2.32623515 |
| 50 | Elevated alkaline phosphatase (HP:0003155) | 2.31613681 |
| 51 | Prolonged bleeding time (HP:0003010) | 2.30491294 |
| 52 | Renal tubular dysfunction (HP:0000124) | 2.29386773 |
| 53 | Myocardial infarction (HP:0001658) | 2.21720578 |
| 54 | Hypokalemia (HP:0002900) | 2.15227036 |
| 55 | Poikilocytosis (HP:0004447) | 2.13785629 |
| 56 | Hyperammonemia (HP:0001987) | 2.11363484 |
| 57 | Hypoplastic labia majora (HP:0000059) | 2.08608864 |
| 58 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.07211279 |
| 59 | Abnormality of alkaline phosphatase activity (HP:0004379) | 2.05856916 |
| 60 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.04223166 |
| 61 | Postural instability (HP:0002172) | 2.04116242 |
| 62 | Hypolipoproteinemia (HP:0010981) | 2.01760921 |
| 63 | Spontaneous abortion (HP:0005268) | 2.01452421 |
| 64 | Deep venous thrombosis (HP:0002625) | 11.7185265 |
| 65 | Hepatoblastoma (HP:0002884) | 1.98343907 |
| 66 | Increased serum ferritin (HP:0003281) | 1.97882248 |
| 67 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.96621510 |
| 68 | Purpura (HP:0000979) | 1.95780754 |
| 69 | Truncal obesity (HP:0001956) | 1.90360625 |
| 70 | Abnormality of subcutaneous fat tissue (HP:0001001) | 1.88892818 |
| 71 | Abnormality of the labia majora (HP:0012881) | 1.87804658 |
| 72 | Abnormality of iron homeostasis (HP:0011031) | 1.84672148 |
| 73 | Polycythemia (HP:0001901) | 1.84489991 |
| 74 | Epistaxis (HP:0000421) | 1.84322039 |
| 75 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 1.83063613 |
| 76 | Gingival bleeding (HP:0000225) | 1.82688903 |
| 77 | Acute hepatic failure (HP:0006554) | 1.80158117 |
| 78 | Epidermoid cyst (HP:0200040) | 1.79774862 |
| 79 | Enlarged kidneys (HP:0000105) | 1.79004635 |
| 80 | Hepatocellular carcinoma (HP:0001402) | 1.78453405 |
| 81 | Abnormality of potassium homeostasis (HP:0011042) | 1.78104663 |
| 82 | Chin dimple (HP:0010751) | 1.75682729 |
| 83 | Congenital sensorineural hearing impairment (HP:0008527) | 1.75499252 |
| 84 | Cortical dysplasia (HP:0002539) | 1.74836975 |
| 85 | Increased mean platelet volume (HP:0011877) | 1.70227200 |
| 86 | Esophageal varix (HP:0002040) | 1.67307785 |
| 87 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.66028136 |
| 88 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.65068835 |
| 89 | Anorexia (HP:0002039) | 1.61764344 |
| 90 | Abdominal distention (HP:0003270) | 1.61088055 |
| 91 | Genetic anticipation (HP:0003743) | 1.57847977 |
| 92 | Thyroid carcinoma (HP:0002890) | 1.56514113 |
| 93 | Hyperglycinemia (HP:0002154) | 1.55976505 |
| 94 | Late onset (HP:0003584) | 1.55084984 |
| 95 | Decreased muscle mass (HP:0003199) | 1.53989934 |
| 96 | Thoracolumbar scoliosis (HP:0002944) | 1.53421567 |
| 97 | Delayed puberty (HP:0000823) | 1.50869697 |
| 98 | Bifid scrotum (HP:0000048) | 1.50157115 |
| 99 | Spastic paraparesis (HP:0002313) | 1.49125499 |
| 100 | Progressive visual loss (HP:0000529) | 1.46997422 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BLK | 7.30649246 |
| 2 | FRK | 5.20368655 |
| 3 | TAOK3 | 4.18101404 |
| 4 | TAOK1 | 3.27243382 |
| 5 | CAMK1G | 3.02534751 |
| 6 | PNCK | 2.95870726 |
| 7 | PIK3CA | 2.55981155 |
| 8 | LATS1 | 2.44037568 |
| 9 | WNK3 | 2.29841744 |
| 10 | CAMK1D | 2.14167277 |
| 11 | ACVR1B | 2.11306646 |
| 12 | FGFR2 | 1.94187508 |
| 13 | GRK1 | 1.92752942 |
| 14 | MAP4K2 | 1.79958228 |
| 15 | BMPR1B | 1.72941050 |
| 16 | MAP3K2 | 1.39393372 |
| 17 | NEK6 | 1.34711114 |
| 18 | NEK9 | 1.25453363 |
| 19 | PRKCG | 1.20632375 |
| 20 | INSRR | 1.19475192 |
| 21 | SIK2 | 1.18138927 |
| 22 | PLK4 | 1.11828553 |
| 23 | MUSK | 1.11179335 |
| 24 | WNK1 | 1.04816804 |
| 25 | MAPK13 | 1.04362799 |
| 26 | PRKACG | 0.96340708 |
| 27 | STK11 | 0.95609231 |
| 28 | STK38L | 0.91324359 |
| 29 | PRKAA1 | 0.87648608 |
| 30 | NTRK2 | 0.86126743 |
| 31 | TIE1 | 0.85864535 |
| 32 | JAK2 | 0.85767683 |
| 33 | PRKAA2 | 0.81768515 |
| 34 | SGK2 | 0.80044585 |
| 35 | WNK4 | 0.79458880 |
| 36 | ADRBK2 | 0.79456242 |
| 37 | RIPK1 | 0.78325481 |
| 38 | PRKG1 | 0.77971057 |
| 39 | YES1 | 0.76372994 |
| 40 | LATS2 | 0.76227963 |
| 41 | AKT3 | 0.75091045 |
| 42 | TGFBR1 | 0.74110051 |
| 43 | NTRK3 | 0.71798411 |
| 44 | CDK12 | 0.70134710 |
| 45 | SGK1 | 0.69895793 |
| 46 | MARK1 | 0.68987433 |
| 47 | NTRK1 | 0.64502343 |
| 48 | STK39 | 0.63376378 |
| 49 | STK38 | 0.61619267 |
| 50 | PIK3CG | 0.61275119 |
| 51 | PAK3 | 0.60856183 |
| 52 | IGF1R | 0.59097890 |
| 53 | MAP2K1 | 0.58034896 |
| 54 | SGK494 | 0.57631036 |
| 55 | SGK223 | 0.57631036 |
| 56 | CSNK1E | 0.57002070 |
| 57 | PRKCB | 0.56506095 |
| 58 | SYK | 0.56097161 |
| 59 | CSNK1D | 0.54552573 |
| 60 | PKN1 | 0.52665113 |
| 61 | BCR | 0.51541399 |
| 62 | RPS6KB1 | 0.51419417 |
| 63 | BMPR2 | 0.50784403 |
| 64 | PRKACB | 0.50103499 |
| 65 | MAP3K4 | 0.49536395 |
| 66 | MST4 | 0.47569496 |
| 67 | OXSR1 | 0.47211599 |
| 68 | MAPK1 | 0.45521294 |
| 69 | FGFR1 | 0.44149346 |
| 70 | ADRBK1 | 0.44029978 |
| 71 | RPS6KA3 | 0.43039564 |
| 72 | FYN | 0.42861778 |
| 73 | SGK3 | 0.42533134 |
| 74 | CAMK2G | 0.42287145 |
| 75 | PDGFRB | 0.41516935 |
| 76 | NLK | 0.41239195 |
| 77 | PRKACA | 0.41005640 |
| 78 | CSNK1A1 | 0.40980959 |
| 79 | CAMK2B | 0.39712825 |
| 80 | PRKCE | 0.38393855 |
| 81 | PRKCA | 0.38082492 |
| 82 | CAMK1 | 0.37917451 |
| 83 | MYLK | 0.36291137 |
| 84 | FGFR3 | 0.35838051 |
| 85 | CASK | 0.34679371 |
| 86 | RPS6KA5 | 0.34524040 |
| 87 | PRKCZ | 0.34249610 |
| 88 | PRKCI | 0.33932518 |
| 89 | MAPK14 | 0.33900069 |
| 90 | ZAP70 | 0.33812851 |
| 91 | MAPK3 | 0.33202591 |
| 92 | MAPK11 | 0.32937782 |
| 93 | MET | 0.32692660 |
| 94 | DAPK2 | 0.32582560 |
| 95 | FLT3 | 0.32191864 |
| 96 | IRAK4 | 0.31728522 |
| 97 | MAP3K7 | 0.30658084 |
| 98 | ERBB4 | 0.30268136 |
| 99 | DYRK2 | 0.29498851 |
| 100 | ABL1 | 0.29216629 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 4.82189603 |
| 2 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.18842892 |
| 3 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.86010450 |
| 4 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 3.67968195 |
| 5 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 3.18004107 |
| 6 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 3.15828208 |
| 7 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 3.13621962 |
| 8 | Retinol metabolism_Homo sapiens_hsa00830 | 3.06038421 |
| 9 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 2.87907297 |
| 10 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.83782609 |
| 11 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.78561310 |
| 12 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 2.75420665 |
| 13 | Histidine metabolism_Homo sapiens_hsa00340 | 2.59420720 |
| 14 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.44834333 |
| 15 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 2.12447035 |
| 16 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 2.10784087 |
| 17 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 2.05170154 |
| 18 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.96627624 |
| 19 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.95382431 |
| 20 | Bile secretion_Homo sapiens_hsa04976 | 1.86957565 |
| 21 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.85869650 |
| 22 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.81576944 |
| 23 | ABC transporters_Homo sapiens_hsa02010 | 1.77276618 |
| 24 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.66574308 |
| 25 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.40453645 |
| 26 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 1.34118898 |
| 27 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.32415804 |
| 28 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.29906732 |
| 29 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.27687175 |
| 30 | Peroxisome_Homo sapiens_hsa04146 | 1.21920046 |
| 31 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.21203394 |
| 32 | Circadian rhythm_Homo sapiens_hsa04710 | 1.16130872 |
| 33 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.11438558 |
| 34 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.06534920 |
| 35 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.05444748 |
| 36 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.05201784 |
| 37 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.01327487 |
| 38 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.00177676 |
| 39 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.98993969 |
| 40 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.92337195 |
| 41 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.91046651 |
| 42 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.88680362 |
| 43 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.85652089 |
| 44 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.80132189 |
| 45 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.75300288 |
| 46 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.71042560 |
| 47 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.70199336 |
| 48 | Insulin resistance_Homo sapiens_hsa04931 | 0.68808456 |
| 49 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.67298735 |
| 50 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.65204112 |
| 51 | Nicotine addiction_Homo sapiens_hsa05033 | 0.60495493 |
| 52 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.57858163 |
| 53 | Prion diseases_Homo sapiens_hsa05020 | 0.54120354 |
| 54 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.52111631 |
| 55 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.47885108 |
| 56 | Insulin secretion_Homo sapiens_hsa04911 | 0.44888913 |
| 57 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.44488953 |
| 58 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.44331175 |
| 59 | Pertussis_Homo sapiens_hsa05133 | 0.44188650 |
| 60 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.42368003 |
| 61 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.39367721 |
| 62 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.31941017 |
| 63 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.31811444 |
| 64 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.28473317 |
| 65 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.27977472 |
| 66 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.27459710 |
| 67 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.25657478 |
| 68 | Metabolic pathways_Homo sapiens_hsa01100 | 0.25321899 |
| 69 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.24953336 |
| 70 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.24908114 |
| 71 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.21603750 |
| 72 | Long-term depression_Homo sapiens_hsa04730 | 0.19822712 |
| 73 | Lysine degradation_Homo sapiens_hsa00310 | 0.17073527 |
| 74 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.16476486 |
| 75 | Mineral absorption_Homo sapiens_hsa04978 | 0.16389164 |
| 76 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.15856944 |
| 77 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.14700047 |
| 78 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.13321595 |
| 79 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.13203786 |
| 80 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.10755617 |
| 81 | GABAergic synapse_Homo sapiens_hsa04727 | 0.10689636 |
| 82 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.10468892 |
| 83 | Galactose metabolism_Homo sapiens_hsa00052 | 0.09685059 |
| 84 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.09156276 |
| 85 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.07331208 |
| 86 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.07247320 |
| 87 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.07070279 |
| 88 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.06846195 |
| 89 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.05276405 |
| 90 | * Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.04607525 |
| 91 | Cocaine addiction_Homo sapiens_hsa05030 | 0.03587575 |
| 92 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.03284098 |
| 93 | Amoebiasis_Homo sapiens_hsa05146 | 0.02734378 |
| 94 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.02182417 |
| 95 | Phototransduction_Homo sapiens_hsa04744 | 0.02126402 |
| 96 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.01370987 |
| 97 | Platelet activation_Homo sapiens_hsa04611 | 0.00425959 |
| 98 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.00390355 |
| 99 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.00035440 |
| 100 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | -0.0174374 |

